Curaleaf Holdings (Curaleaf Holdings) Cash-to-Debt : 0.12 (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Curaleaf Holdings Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Curaleaf Holdings's cash to debt ratio for the quarter that ended in Mar. 2024 was 0.12.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Curaleaf Holdings couldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2024.

The historical rank and industry rank for Curaleaf Holdings's Cash-to-Debt or its related term are showing as below:

CURLF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.07 Med: 0.47 Max: No Debt
Current: 0.12

During the past 10 years, Curaleaf Holdings's highest Cash to Debt Ratio was No Debt. The lowest was 0.07. And the median was 0.47.

CURLF's Cash-to-Debt is ranked worse than
82.71% of 989 companies
in the Drug Manufacturers industry
Industry Median: 0.96 vs CURLF: 0.12

Curaleaf Holdings Cash-to-Debt Historical Data

The historical data trend for Curaleaf Holdings's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Curaleaf Holdings Cash-to-Debt Chart

Curaleaf Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash-to-Debt

Get a 7-Day Free Trial

0.21

0.13

0.40

0.18

0.10

Curaleaf Holdings Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash-to-Debt	Get a 7-Day Free Trial															0.13	0.10	0.13	0.10	0.12

Competitive Comparison of Curaleaf Holdings's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Curaleaf Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Curaleaf Holdings's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curaleaf Holdings's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Curaleaf Holdings's Cash-to-Debt falls into.

Curaleaf Holdings Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Curaleaf Holdings's Cash to Debt Ratio for the fiscal year that ended in Dec. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	91.818	/	(64.899	+	818.648)
	=	0.10

Curaleaf Holdings's Cash to Debt Ratio for the quarter that ended in Mar. 2024 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	105.029	/	(130.688	+	740.978)
	=	0.12

Curaleaf Holdings (OTCPK:CURLF) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Curaleaf Holdings Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Curaleaf Holdings's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Curaleaf Holdings (Curaleaf Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curaleaf Holdings Inc (OTCPK:CURLF) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

CURA:Canada

Address

420 Lexington Avenue, Suite 2035, New York, NY, USA, 10170-0052

Website

https://www.curaleaf.com

Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 18 states. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.